Aldosterone Antagonism in Atrial Fibrillation: Implications for AF-Predominant HFpEF

J Am Heart Assoc. 2020 Sep 15;9(18):e018396. doi: 10.1161/JAHA.120.018396. Epub 2020 Sep 10.
No abstract available

Keywords: Editorials; atrial fibrillation; heart failure; randomized controlled trial.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Aldosterone
  • Atrial Fibrillation* / complications
  • Atrial Fibrillation* / drug therapy
  • Heart Failure* / drug therapy
  • Humans
  • Mineralocorticoid Receptor Antagonists / therapeutic use
  • Spironolactone
  • Stroke Volume

Substances

  • Mineralocorticoid Receptor Antagonists
  • Spironolactone
  • Aldosterone